Search
Search Results
##search.searchResults.foundPlural##
-
Acquired Hemophilia A successfully treated with rituximab
1935PDF: 1142HTML: 1458Figure 1: 175 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1240PDF: 985HTML: 210 -
HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?
2880PDF: 1360HTML: 3569Untitled: 192Untitled: 202Untitled: 177 -
THE ROLE OF WHITE BLOOD CELL COUNT IN PERIANAL PATHOLOGIES: A RETROSPECTIVE ANALYSIS OF HEMATOLOGIC MALIGNANCIES Role of white blood cell count in perianal pathologies
3069PDF: 1867HTML: 237 -
INCIDENCE OF ACUTE MYELOID LEUKEMIA AFTER BREAST CANCER
3245PDF: 934HTML: 2953 -
REFRACTORY THROMBOCYTOPENIA AND NEUTROPENIA: A DIAGNOSTIC CHALLENGE
12344PDF: 1679HTML: 4169Cover letter: 197Figure 1: 204 -
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4295PDF: 1372HTML: 2039 -
THE ROLE OF THE CAROTID DOPPLER EXAMINATION IN THE EVALUATION OF ATHEROSCLEROTIC CHANGES IN BETA THALASSEMIA PATIENTS
2164PDF: 943HTML: 3000Untitled: 208 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2799PDF: 1006HTML: 5519 -
MODULATING EFFECT OF THE ?158 G? (C?T) XMN-1 POLYMORPHISM IN INDIAN SICKLE CELL PATIENTS
1504PDF: 889HTML: 1428Table: 189 -
PERIOPERATIVE MANAGEMENT OF SICKLE CELL DISEASE: A NARRATIVE REVIEW
8000PDF: 3237HTML: 1224 -
THE EVOLVING ROLE OF RADIOTHERAPY IN EARLY STAGE HODGKIN’S LYMPHOMA
2214PDF: 939HTML: 6783Figure 1: 170 -
EPIDEMIOLOGICAL OVERVIEW OF HODGKIN LYMPHOMA ACROSS THE MEDITERRANEAN BASIN
3528PDF: 1177HTML: 4998Incidence age-standardized rates for HL across the Mediterranean basin: 201 -
ATRA induced Reactive Hemophagocytosis: A Case Report
1218PDF: 589HTML: 2860ATRA induced Reactive Hemophagocytosis: A Case Report: 197 -
DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA
9050PDF: 6057HTML: 87956Fig.1b: 184Fig.1c: 188Fig.2a: 176Fig.2b: 175Fig.4: 188Fig.2c: 183Fig.3: 181Tab.1: 225Tab.2: 206Tab.3: 188Tab.4: 220Fig1a: 181 -
OPTIMIZING TREATMENT, MINIMIZING RISK: THERAPEUTIC DRUG MONITORING IN HEMATOLOGICAL MALIGNANCIES
1033PDF: 1209Suppl. Files: 146HTML: 69 -
A MULTICENTER EXPERIENCE FROM LEBANON IN CHILDHOOD AND ADOLESCENT ACUTE MYELOID LEUKEMIA:HIGH RATE OF EARLY DEATH IN CHILDHOOD ACUTE PROMYELOCYTIC LEUKEMIA.
2069PDF: 1114HTML: 7692cover letter paper final AML: 214 -
END-OF-LIFE CARE IN SICKLE CELL DISEASE AND TRASFUSION DEPENDEND-β-THALASSEMIA: CLINICAL, PSYCHOLOGICAL, AND ETHICAL CONSIDERATION Challenges in Supportive Care, Equity, and Compassion at End of Life
993PDF: 659Html: 156 -
The diagnostic pitfalls of mucormycosis
911PDF: 714HTML: 249 -
Diagnosis of del(5q) MDS, 14 years after JAK-2 positive PV appearance: complete remission of both diseases with lenalidomide monotherapy
2781PDF: 765HTML: 1268Blood Count trend before and during lenalidomide treatment: 170Light micrograph of bone marrow biopsy of a patient with PV and 5q deletion: 187 -
OLDER ADULTS WITH PH NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA: A MONOCENTRIC EXPERIENCE ON CONSECUTIVE PATIENTS AGED MORE THAN 55 YEARS Older Adults with Ph Negative Acute Lymphoblastic Leukemia
1293PDF: 563Suppl. Files: 343HTML: 144 -
-
PERPHERAL BLOOD CELL MITOCHONDRIAL DYSFUNCTION IN MYELODYSPLASTIC SYNDROMECAN BE IMPROVED BY A COMBINATION OF COENZYME Q10 AND CARNITINE Blood cell mitochondrial dysfunction in myelodysplastic syndrome
1084PDF: 760HTML: 292







